- The proteomic landscape shows oncologic relevance in cystitis glandularis
-
Kim JY, Han D, Kim H, Jung M, Ryu HS
- KMID: 2539038
- J Pathol Transl Med.
- 2023 Jan;57(1):67-74.
- doi: 10.4132/jptm.2022.10.24
Background: The relationship between cystitis glandularis (CG) and bladder malignancy remains unclear. Methods: We identified the oncologic significance of CG at the molecular level using liquid chromatography-tandem mass spectrometry-based proteomic... -
- CITED
-
- Close
- SHARE
-
- Close
- Silver Nanoparticles Exert Apoptotic Activity in Bladder Cancer 5637 Cells Through Alteration of Bax/Bcl-2 Genes Expression
-
Daei S, Ziamajidi N, Abbasalipourkabir R, Aminzadeh Z, Vahabirad M
- KMID: 2533275
- Chonnam Med J.
- 2022 Sep;58(3):102-109.
- doi: 10.4068/cmj.2022.58.3.102
Bladder cancer is defined as a urinary tract malignancy that threatens men’s and women’s health. Due to the side effects of common chemotherapies, novel therapeutic strategies are necessary to overcome... -
- CITED
-
- Close
- SHARE
-
- Close
- Laparoscopic radical cystectomy with pelvic lymph node dissection and ileal orthotopic neobladder by a total extraperitoneal approach: Our initial technique and short-term outcomes
-
Zhu G, Zhang Z, Zhao K, Yin X, Zhang Y, Wang Z, Li C, Sui Y, Li X, Yang H, Xing N, Wang K
- KMID: 2532885
- Investig Clin Urol.
- 2022 Sep;63(5):523-530.
- doi: 10.4111/icu.20220156
Purpose: With the increasing application of laparoscopic or robot-assisted radical cystectomy, a reliable and promising method is needed for reducing postoperative complications. We describe the short-term outcomes of totally extraperitoneal... -
- CITED
-
- Close
- SHARE
-
- Close
- External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer
-
Kim JY, Lee DB, Song WH, Lee SS, Park SW, Nam JK
- KMID: 2532886
- Investig Clin Urol.
- 2022 Sep;63(5):531-538.
- doi: 10.4111/icu.20220190
Purpose: This study aimed to validate the newly proposed risk model in Korean patients diagnosed with non-muscle-invasive bladder cancer (NMIBC). Materials and Methods: A retrospective review was performed with 1,238 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- A novel strategy for treatment of bladder cancer: Antibody-drug conjugates
-
Kim JH, Chang IH
- KMID: 2530906
- Investig Clin Urol.
- 2022 Jul;63(4):373-384.
- doi: 10.4111/icu.20220061
In the past, there was no second-line chemotherapeutic agent suitable for use when urothelial carcinoma (UC) progressed to platinum-resistant UC. However, recently, several new treatment options, such as immune checkpoint... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy
-
Kim R, Hong JY, Lee J, Kwon GY, Jeong BC, Park SH
- KMID: 2531335
- Cancer Res Treat.
- 2022 Jul;54(3):894-906.
- doi: 10.4143/crt.2021.854
Purpose This study aimed to explore the genomic and transcriptomic landscape of bladder cancer (BC) and its implication for treatment with an immune checkpoint inhibitor (ICI). Materials and Methods We analyzed... -
- CITED
-
- Close
- SHARE
-
- Close
- Next-generation Proteomics-Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
-
Suh J, Han D, Ku JH, Kim HH, Kwak C, Jeong CW
- KMID: 2531334
- Cancer Res Treat.
- 2022 Jul;54(3):882-893.
- doi: 10.4143/crt.2021.642
Purpose We aimed to identify, verify, and validate a multiplex urinary biomarker-based prediction model for diagnosis and surveillance of urothelial carcinoma of bladder, using high-throughput proteomics methods. Materials and Methods Label-free quantification... -
- CITED
-
- Close
- SHARE
-
- Close
- Bladder Cancer Metastasis to the Breast in a Male Patient: Imaging Findings on Mammography and Ultrasonography
-
Yoon IN, Cha ES, Kim JH, Lee JE, Chung J
- KMID: 2530056
- J Korean Soc Radiol.
- 2022 May;83(3):687-692.
- doi: 10.3348/jksr.2021.0070
Male breast cancer is rare, accounting for approximately 1% of breast cancers. Metastasis from extra-mammary malignancy to the breast in men is extremely rare. The most common primary tumors that... -
- CITED
-
- Close
- SHARE
-
- Close
- Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials
-
Choi SY, Ha MS, Kim JH, Chi BH, Kim JW, Chang IH, Kim TH, Myung SC
- KMID: 2526905
- Investig Clin Urol.
- 2022 Mar;63(2):140-150.
- doi: 10.4111/icu.20210340
Purpose: Intravesical BCG (bacille Calmette–Guérin) instillation in patients with non-muscle-invasive bladder cancer decreases the risk for tumor recurrence and progression. After one BCG product was discontinued, a chronic global BCG... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer
-
Ku JY, Hwang EC, Lee CH, Kim KH, Kwon DD, Ha HK
- KMID: 2527251
- Korean J Urol Oncol.
- 2022 Feb;20(1):52-58.
- doi: 10.22465/kjuo.2022.20.1.52
Purpose: The aims of this study were to investigate the clinical value of Rab27a as a urinary biomarker, and its efficiency in the prediction of bladder cancer grade. Materials and Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors
-
Kim SH, Park EY, Lee HH, Chung J, Seo HK
- KMID: 2527248
- Korean J Urol Oncol.
- 2022 Feb;20(1):25-33.
- doi: 10.22465/kjuo.2022.20.1.25
Purpose: This study aimed to determine the prognostic roles of several immune-related laboratory parameters in patients with metastatic kidney and bladder cancer treated with immune checkpoint inhibitors (ICIs). Materials and Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
-
Jeong J, Ha JB, Chang IH
- KMID: 2527247
- Korean J Urol Oncol.
- 2022 Feb;20(1):12-24.
- doi: 10.22465/kjuo.2022.20.1.12
For intermediate- and high-risk nonmuscle invasive bladder cancer (NMIBC), intravesical Bacillus Calmette-Guérin (BCG) therapy is the standard adjuvant treatment following transurethral resection of bladder tumor. Although intravesical BCG therapy improves... -
- CITED
-
- Close
- SHARE
-
- Close
- Gender-related outcomes in robot-assisted radical cystectomy: A multi-institutional study
-
Jin HJ, Shim JS, Kwon TG, Kim TH, Jeon SH, Lee SH, Kang SG, Nam JK, Kim WS, Jeong BC, Oh JJ, Lee SC, Lee JY, Hong SH, Rha KH, Han WK, Ham WS, Lee YG, Lee YS, Park SY, Yoon YE, Ku JH, Kang SH
- KMID: 2524276
- Investig Clin Urol.
- 2022 Jan;63(1):53-62.
- doi: 10.4111/icu.20210334
Purpose: Robot-assisted radical cystectomy (RARC) optimizes patient recovery and has outcomes comparable with those of open surgery. This study aimed to compare the perioperative and oncologic outcomes of RARC in... -
- CITED
-
- Close
- SHARE
-
- Close
- Presence and predominance of histological grade 3 define cT1HG bladder cancer prognostic groups
-
Reis LO, Col LSBD, Capibaribe DM, Mendonça GBd, Denardi F, Billis A
- KMID: 2524266
- Investig Clin Urol.
- 2022 Jan;63(1):21-26.
- doi: 10.4111/icu.20210386
Purpose: Current World Health Organization/International Society of Urological Pathology (2004 WHO/ISUP) grading of bladder urothelial carcinoma relies on the highest pathologic grade of the specimen and does not reflect the... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors
-
Lee K, Jeong Sh, Yoo SH, Ku JH
- KMID: 2524265
- Investig Clin Urol.
- 2022 Jan;63(1):14-20.
- doi: 10.4111/icu.20210314
Purpose: The need for secondary transurethral resection of the bladder (re-TURB) in patients with high-grade Ta tumors has not been assessed. This study aimed to compare the outcomes of patients... -
- CITED
-
- Close
- SHARE
-
- Close
- The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
-
Jeong H, Park KJ, Lee Y, Kim HD, Kim JH, Yoon S, Hong B, Lee JL
- KMID: 2524603
- Cancer Res Treat.
- 2022 Jan;54(1):226-233.
- doi: 10.4143/crt.2021.365
Purpose This study aims to evaluate the prognosis of pathologically node-positive bladder cancer after neoadjuvant chemotherapy, the role of adjuvant chemotherapy in these patients, and the value of preoperative clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Perioperative Outcomes of Different Surgical Methods Among Bladder Cancer Patients Undergoing Radical Cystectomy With Neobladder Urinary Diversion
-
Kim HJ, Ye C, Kim JH, Kim H, Lee S, Byun SS, Oh JJ
- KMID: 2522847
- Korean J Urol Oncol.
- 2021 Nov;19(4):261-270.
- doi: 10.22465/kjuo.2021.19.4.261
Purpose: To compare perioperative outcomes according to surgical methods among bladder cancer patients who underwent radical cystectomy (RC) with neobladder urinary diversion. Materials and Methods: Between June 2007 and January 2020,... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
-
Han MA, Maisch P, Jung JH, Hwang JE, Narayan V, Cleves A, Hwang EC, Dahm P
- KMID: 2521813
- Investig Clin Urol.
- 2021 Nov;62(6):623-630.
- doi: 10.4111/icu.20210265
Purpose: To assess the comparative effectiveness and toxicity of intravesical gemcitabine instillation for non-muscle invasive bladder cancer (NMIBC). Materials and Methods: We performed a comprehensive literature search on 11 September 2020.... -
- CITED
-
- Close
- SHARE
-
- Close
- Urothelial Carcinoma of the Bladder: Radiologic Perspective
-
Kim DW, Yoon SK, Kim SH
- KMID: 2520679
- J Korean Soc Radiol.
- 2021 Sep;82(5):1033-1052.
- doi: 10.3348/jksr.2021.0112
Bladder cancer is a relatively common cancer type, with a high recurrence rate, that can be often encountered in the imaging study. Accurate diagnosis and staging have a significant impact... -
- CITED
-
- Close
- SHARE
-
- Close
- Prominence of urinary biomarkers for bladder cancer in the COVID-19 era: From the commercially available to new prospective candidates
-
Piao XM, Kang H, Kim WJ, Yun SJ
- KMID: 2519521
- Investig Clin Urol.
- 2021 Sep;62(5):500-519.
- doi: 10.4111/icu.20210194
Molecular markers detected in urine may improve our understanding of the evolution of bladder cancer (BCa) and its micro- and macroenvironment. Detection of such markers will identify disease earlier, allow... -
- CITED
-
- Close
- SHARE
-
- Close
